Discounted Cash Flow
Bio-techne Corp.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $499.0m | $104.5m | $127.0m | 20.9% | $2.81 |
| 2017 | $563.0m (12.8%) | $76.1m (-27.2%) | $128.3m (1.0%) | 13.5% (-35.4%) | $2.04 (-27.4%) |
| 2018 | $643.0m (14.2%) | $126.2m (65.8%) | $149.4m (16.5%) | 19.6% (45.2%) | $3.36 (64.7%) |
| 2019 | $714.0m (11.0%) | $96.1m (-23.8%) | $156.2m (4.5%) | 13.5% (-31.4%) | $2.54 (-24.4%) |
| 2020 | $738.7m (3.5%) | $229.3m (138.7%) | $153.5m (-1.8%) | 31.0% (130.7%) | $6.00 (136.2%) |
| 2021 | $931.0m (26.0%) | $140.4m (-38.8%) | $307.9m (100.6%) | 15.1% (-51.4%) | $3.62 (-39.7%) |
| 2022 | $1.1b (18.7%) | $272.1m (93.8%) | $280.4m (-8.9%) | 24.6% (63.2%) | $6.93 (91.4%) |
| 2023 | $1.1b (2.8%) | $285.3m (4.9%) | $216.1m (-22.9%) | 25.1% (2.0%) | $1.81 (-73.9%) |
| 2024 | $1.2b (2.0%) | $168.1m (-41.1%) | $236.1m (9.2%) | 14.5% (-42.2%) | $1.07 (-40.9%) |
| 2025 | $1.2b (5.2%) | $73.4m (-56.3%) | $256.6m (8.7%) | 6.0% (-58.5%) | $0.47 (-56.1%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.